Interactions driven by the T cell antigen receptor (TCR) determine the lineage fate of CD4 + CD8 + thymocytes, but the molecular mechanisms that induce the lineage-determining transcription factors are unknown. Here we found that TCR-induced transcription factors Egr2 and Egr1 had higher and more-prolonged expression in precursors of the natural killer T (NKT) than in cells of conventional lineages. Chromatin immunoprecipitation followed by deep sequencing showed that Egr2 directly bound and activated the promoter of Zbtb16, which encodes the NKT lineage-specific transcription factor PLZF. Egr2 also bound the promoter of Il2rb, which encodes the interleukin 2 (IL-2) receptor b-chain, and controlled the responsiveness to IL-15, which signals the terminal differentiation of the NKT lineage. Thus, we propose that persistent higher expression of Egr2 specifies the early and late stages of NKT lineage differentiation, providing a discriminating mechanism that enables TCR signaling to 'instruct' a thymic lineage.
Natural killer T cells (NKT cells) are a conserved population of innatelike T cells that recognize complexes of the antigen-presenting molecule CD1d and lipid and rapidly produce an extensive assortment of cytokines and chemokines able to modulate immunity to many conditions, including infection, cancer, autoimmunity and allergy 1, 2 . Most NKT cells express the canonical T cell antigen receptor (TCR) α-chain composed of α-chain variable region 14 and α-chain joining region 18 (V α 14-J α 18), which arises randomly during thymic development at the CD4 + CD8 + double-positive stage and, together with the TCR V β 8, V β 7 or V β 2 chain, confers specificity for self lipid ligands expressed by cortical thymocytes to 'instruct' differentiation into the NKT lineage. Tetramers of CD1d in complex with the synthetic ligand α-galactosylceramide (α-GalCer), a mimetic of microbial lipid antigens, readily identify the rare NKT precursors that have just undergone positive selection in the thymus 3 . This so-called 'stage zero' is characterized by a CD4 + CD69 + CD24 hi phenotype equivalent to that of the transitional stage of major histocompatibility complex (MHC)-restricted T cells. Cells at stage 1 downregulate CD24 and have a CD44 lo naive phenotype equivalent to mature CD4 + single-positive thymocytes. However, these cells have already initiated a program of cell division and effector differentiation, which culminates at stage 2, when cells have a memory-like CD44 hi phenotype and leave the thymus. Progression to stage 3 is marked by the cessation of cell division and the acquisition of an NK cell-like program. This terminal differentiation occurs in the periphery, although a small fraction of cells can remain resident in the thymus, where they also differentiate to stage 3.
As in other cells of the αβ T cell lineage, TCR signaling is thought to instruct development into the NKT lineage through the expression of signature transcription factors. The transcription factor PLZF (encoded by Zbtb16) directs acquisition of the NKT cell effector program during development, including the cytokine and migratory properties of NKT cells [4] [5] [6] [7] . The expression of PLZF in thymic NKT cell development is tightly regulated, as it is first induced in 40% of cells at stage zero and has peak expression in 100% of cells at stage 1 and stage 2. Mutations in Zbtb16 abrogate the memoryeffector differentiation of NKT cells, which results in their reversal to a naive phenotype and redistribution to the lymph nodes rather than to the liver and other organs where they normally predominate. Moreover, constitutive equivalent expression of PLZF during thymic development induces the effector program in all conventional T cells independently of their antigen specificity 8 . Thus, PLZF represents a pivotal signature transcription factor of the NKT cell lineage. Given the temporal proximity of PLZF expression to lineage bifurcation, we hypothesized that the transcriptional control elements required for PLZF expression would be among the earliest determinants of lineage commitment.
Although differences in TCR signaling are thought to instruct the expression of lineage-determining factors, such as c-Krox (Th-POK; encoded by Zbtb7b) for the CD4 + T cell lineage or Foxp3 (encoded by Foxp3) for regulatory T cells, the identities of the signaling molecules involved in gene regulation are unknown. Egr1, Egr2 and Egr3 are among the earliest transcription factors induced by TCR signaling, A r t i c l e s and their redundant roles in activating the survival program associated with the positive selection of T cells is well established [9] [10] [11] . Thus, combined ablation of Egr1 and Egr2 impairs the thymic generation of T cells as well as of NKT cells. Ablation of Egr2 alone, however, is sufficient to substantially impair the survival of NKT cells but not of conventional T cell precursors, which indicates some unique function for this factor in the NKT lineage 12, 13 . Furthermore, transgenic expression of the antiapoptotic protein Bcl-2 (ref. 13) does not restore the NKT lineage in Egr2-deficient mice, which suggests Egr2 is not solely required for survival but might also have a direct role in lineage differentiation. This is consistent with data reported before, for example, for myeloid precursors, in which Egr2 is at the center of a transcriptional regulatory network that promotes macrophage genes and represses neutrophil genes 14 .
In this study, we found higher, more-sustained expression of Egr2 and, to a lesser extent, Egr1 in precursors of NKT cells than in conventional T cells undergoing positive selection. Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) showed that Egr2 directly bound and activated the promoter of Zbtb16, which resulted in expression of PLZF. Furthermore, we identified a crucial role for Egr2 in conferring responsiveness to interleukin 15 (IL-15). Our findings demonstrate a direct link between TCR signaling and the key stages of commitment and differentiation in the NKT lineage.
RESULTS

Higher expression of Egr1 and Egr2 in NKT cell thymic precursors
Measuring the natural expression of TCR signaling intermediates in thymocytes represents a technical challenge because of the weak and transient nature of signaling during development and the limiting numbers of cells at different stages. We used confocal microscopy of single cells to quantify and compare the expression of Egr2 during the development of conventional T cells and NKT cells. At the CD24 hi CD69 hi CD4 + stage immediately after engagement of the TCR by natural ligands in vivo (called the 'transitional CD4 + stage' , for MHC-restricted T cells, or 'stage 0' , for NKT cells), both lineages had induction of Egr2 above the baseline in CD4 + CD8 + double-positive thymocytes, but V α 14-transgenic cells had Egr2 expression twice that of wild-type T cells, on average ( Fig. 1a) . Even after developing past the CD24 lo CD44 lo NK1.1stage 1 and maturing to the CD24 lo CD44 hi NK1.1 − stage 2 that immediately precedes thymic emigration, V α 14-transgenic cells maintained higher Egr2 expression than that of the cells in the equivalent CD24 lo stage of MHC-restricted CD4 + single-positive thymocytes (Fig. 1b) . In fact, at all stages of development and maturation, including the CD24 lo CD44 hi NK1.1 + stage 3, which represents the terminal NK cell-like differentiated state of this lineage, NKT thymocytes identified by tetramer staining had higher expression of Egr2 than did conventional T cells ( Fig. 1c) . We confirmed the confocal microscopy findings by intracellular flow cytometry with a different monoclonal antibody to Egr2 (anti-Egr2; Fig. 1d ). We detected a similar increase in Egr1 expression, although this subsided significantly at stage 1 (Fig. 1e) . Thus, NKT thymocytes had a greater and more sustained increase in expression of Egr1 and Egr2 after selection than did MHC-restricted thymocytes.
Strong TCR signals induce Egr2 and PLZF in vivo
Because Egr1 expression is dependent on the GTPase Ras-mitogenactivated protein kinase pathway and Egr2 is dependent mainly on the calcineurin-transcription factor NFAT pathway downstream of TCR signaling 9, 12, 15 , the data presented above suggested that NKT cell Figure 1 Higher and more-prolonged expression of Egr1 and Egr2 in thymic precursors of NKT cells. (a) Fluorescence intensity of Egr2 measured by confocal microscopy of individual cells from wild-type (WT) and V α 14-transgenic (V α 14-TG) mice, isolated into CD4 + and CD4 + transitional (CD4 + t) thymocyte subsets. (b) Fluorescence intensity of Egr2 measured by confocal microscopy of thymocytes sorted from wild-type mice as mature CD24 lo CD4 + cells and from V α 14-transgenic mice as CD24 lo CD44 + NK1.1 -CD4 + cells (stage 2) or CD1d-α-GalCer tetramer-positive (Tet + ) cells (stages 0-3). Left, baseline staining of V α 14-transgenic Tet + thymocytes by immunoglobulin G (IgG; control). (c) Fluorescence intensity of Egr2 measured by confocal microscopy of CD4 + CD8 + (DP), transitional CD4 + and mature CD4 + or CD8 + thymocytes sorted from wild-type mice and in Tet + NKT thymocytes sorted at stage 0 (CD24 hi CD69 + ), stage 1 (CD24 lo CD44 lo NK1.1 -), stage 2 (CD24 lo CD44 hi NK1.1 -) and stage 3 (CD24 lo CD44 hi NK1.1 + ) from V α 14-transgenic mice. Red circles indicate cells in images below. DAPI, DNA-intercalating dye. Scale bar, 5 µm. (d) Intracellular flow cytometry staining of Egr2 in CD4 + single-positive thymocytes from wild-type and Egr2 ∆/∆ nontransgenic (non-TG) mice and in Tet + thymocytes from wild-type and Egr2 ∆/∆ V α 14-transgenic mice. (e) Fluorescence intensity of Egr1 measured by confocal microscopy of CD4 + transitional and CD4 + thymocytes sorted from wild-type mice and in thymocytes at stage 0 or stage 1 (identified by tetramer staining) sorted from V α 14-transgenic mice. IgG (left), baseline fluorescence. *P < 0.001 and **P < 0.0001 (two-tailed unpaired t-test). Each symbol (a-c,e) represents an individual cell; small horizontal lines indicate the mean. Data are representative of three (a,c,d) or two (b,e) independent experiments. development is promoted by more TCR signaling, both in quantity and in duration. That conclusion is consistent with published reports showing that NKT cell TCRs are autoreactive and recognize agonist self lipid ligands 16, 17 . We explored whether in addition to its reported survival effects, Egr2 might function to regulate NKT cell fate determination by controlling the induction of PLZF, the signature transcription factor of NKT cells. To assess the potential link among TCR signaling, Egr2 induction and subsequent PLZF expression, we injected mice with anti-TCRβ in vivo and assessed the expression of Egr2 and PLZF in thymocytes that had received signaling via the TCR (CD69 + thymocytes). Egr2 mRNA was rapidly induced after 30 min, reached a maximum at 1 h after injection and remained measurably higher 24 h later ( Fig. 2a) . Zbtb16 mRNA was upregulated with some delay, as it was detectable at 18 h and 24 h ( Fig. 2b) . We also detected Egr2 in whole thymocytes by immunoblot analysis and in CD4 + CD8 + double-positive thymocytes by flow cytometry (Fig. 2c,d) . We further assessed whether Zbtb16 induction depended on Egr1 and Egr2. Because complete blockade of NKT cell development requires ablation of both Egr1 and Egr2 (ref. 13 ), we used double-mutant Egr1-Egr2-deficient mice (with homozygous deletion of Egr1 (Egr1 −/− ) and loxP-flanked Egr2 alleles (Egr2 fl/fl ) deleted by Cre recombinase expressed from the Lck promoter (Egr2 ∆/∆ )) as recipients of anti-TCRβ. Egr1-Egr2-deficient thymocytes had 80% less induction of Zbtb16, on average, than did wild-type thymocytes ( Fig. 2e ). We noted residual Egr2 expression after injection of anti-TCRβ into Egr1-Egr2-deficient mice, which we attributed to incomplete Cre-mediated excision of Egr2 fl/fl in some cells (discussed below). Thus, although this experimental model did not rule out the possibility of cell-extrinsic effects, the data suggested that TCR agonist signaling was associated with rapid induction of Zbtb16 mRNA in an Egr1-Egr2-dependent manner in thymocytes in vivo.
Egr2 binds to critical genes of the NKT lineage in vivo
To test the possibility that Zbtb16 might be a direct target of Egr2, we did unbiased, genome-wide studies of Egr2 binding by ChIP-seq analysis of pools of NKT thymocytes isolated from V α 14-transgenic mice 18 or on total thymocytes from mice given injection of anti-TCRβ. Analysis of the former yielded fewer binding events (peaks) than did analysis of the latter (Fig. 3a) , an expected outcome given the lower abundance of endogenous Egr2 and the limiting numbers of NKT thymocytes that could be recovered. Nevertheless, when we surveyed both data sets for the motifs showing the most frequent enrichment, the sequences identified were essentially the same and were identical to the canonical Egr2-binding motif 19 . Further, the two data sets showed similar patterns of binding with substantial overlap of bound genes, particularly at promoters ( Fig. 3b-d ).
To identify Egr2 target genes encoding molecules with a high probability of involvement in NKT cell development, we compared the list of gene-associated peaks (excluding intergenic peaks) in both ChIP-seq data sets with the list of genes with expression at NKT cell stages 1, 2 and 3 that was >1.8-fold higher than that of CD4 + singlepositive thymocytes. Finally, we further limited the study to genes with a conserved Egr2-binding motif in humans. This analysis led to a short list of nine Egr2 target genes that were specifically upregulated during NKT development ( Table 1) . Four of these genes are known to be pivotal for NKT cell development or function and were bound by Egr2 in their promoter regions (Fig. 3e) . They included Zbtb16; Il2rb, which encodes the β-chain of the receptor for IL-15, essential for the expression of NK receptors and the survival of terminally differentiated NKT cells at stage 3 (refs. 20-22) ; Fasl, which encodes the ligand for the cell surface receptor Fas and is a known target of Egr2 (ref. 15);
and Ccnd2, which encodes the cell-cycle regulator cyclin D2, essential for the population expansion of NKT thymocytes. Thus, unbiased genome-wide studies showed direct binding of Egr2 to the promoters of critical genes of the NKT lineage during development.
Egr2 directly transactivates Zbtb16 expression
After examining the sequence of the Zbtb16 proximal promoter, we located a conserved consensus Egr-binding motif ~240 base pairs upstream of the transcription start site (Fig. 4a) . We further confirmed binding in this region by ChIP and quantitative PCR (Fig. 4b) .
Moreover, electrophoretic mobility-shift assay directly demonstrated binding of in vitro-translated Egr2, in a sequence-specific manner, to an oligonucleotide encompassing the putative binding site (Fig. 4a,c) . Furthermore, after transfection of KG1a human hematopoietic cells with Egr2 together with a luciferase plasmid driven by the Zbtb16 promoter, luciferase expression was substantially induced and depended on the presence of the Egr2-binding site (Fig. 4d) , which provided functional evidence that Egr2 can activate the Zbtb16 promoter. Together these results established Egr2 as a direct transactivator of the Zbtb16 promoter.
Egr2 regulates distinct NKT cell developmental transitions in vivo
Given the unbiased analysis of Egr2 binding reported above, we next examined the effect of ablation of Egr2 on NKT cell-lineage checkpoints in the mouse thymus. To minimize the well-known redundancy and compensation between Egr1 and Egr2, we studied the effects of ablation of Egr1 and Egr2 alone and together in competitive bone marrow chimeras generated by the transplantation of a 1:1 mixture of mutant (CD45.2 + ) bone marrow and wild-type (CD45.1 + ) bone marrow into irradiated wild-type (CD45.1 + ) host mice. In this experimental system, Egr1-deficient NKT cells developed normally, whereas Egr2-deficient thymocytes were arrested between developmental stage 2 and stage 3 (Fig. 5a) . In contrast, Egr1-Egr2deficient thymocytes were sharply arrested earlier, at stage 1 (Fig. 5a ). These precise developmental blocks were highly reproducible ( Fig. 5b) and were generally consistent with published reports 12, 13 of nonchimeric Egr2 ∆/∆ or Egr1-Egr2-deficient mice, although these germline mutant mice have more leaky phenotypes and less complete blocks. To monitor the efficacy of Cre-mediated excision, we also bred Egr1-Egr2-deficient donors to express a reporter allele encoding Cre recombinase linked to green fluorescent protein (GFP) from the Il2rb
Genes upregulated over 1.8-fold (P < 0.05) at stages 1-3 of NKT development relative to their expression in CD4 + single-positive thymocytes (top row), compiled from the ImmGen Consortium microarray data sets 44 and further selected on the basis of binding by Egr2 in the ChIP-seq data sets obtained from V α 14-transgenic NKT thymocytes (second row) and from thymocytes from wild-type mice given injection of anti-TCRβ (third row). Below, final gene list limited to those that met all the criteria above and had a conserved Egr2-binding motif in the analogous human genomic sequence within 200 base pairs of the binding site 'called' by ChIP-seq with the ECR browser (online informatics tool) 45 ; '−' indicates the gene did not achieve the upregulation threshold for the specified developmental stage. (Fig 5a, inset) , which suggested they had failed to delete the Egr2 allele.
Egr2 controls PLZF expression
The early block in Egr1-Egr2-deficient thymocytes was reminiscent of the defect observed in mice lacking the NKT cell lineage-specific transcription factor PLZF 4,5 . Indeed, whereas PLZF expression was tightly controlled during NKT cell development, beginning as early as stage 0, and high expression was present in 100% of cells at stage 1, it was conspicuously absent in the Egr1-Egr2-deficient NKT cells arrested at stage 1 (Fig. 6a) . In contrast, PLZF was induced normally in NKT thymocytes deficient in either Egr1 or Egr2 alone (Fig. 6a) , which indicated that Egr1 was able to compensate for the loss of Egr2 during early NKT development (Fig. 6b) . Together with the ChIP-seq data and the promoter-transactivation studies, these results indicated a direct and critical function for Egr1 and Egr2 in PLZF induction.
Egr2 controls IL-2Rb expression
The late developmental block observed in Egr2-deficient thymocytes was reminiscent of the defects associated with abrogation of IL-15 signaling, as reported in studies of mice with mutant IL-15, receptor IL-15Rα or transcription factor T-bet [20] [21] [22] . IL-15 controls the transition from stage 2 to stage 3 that is defined by the acquisition of the NK cell-like properties intrinsic to the NKT lineage. Using biotinylated double-stranded oligonucleotides and in vitro-translated Egr2 in a streptavidin bead-precipitation assay, we directly showed that Egr2 bound the Il2rb promoter in a sequence-specific manner (Fig. 7a) . The same assay confirmed binding of Egr2 to the Zbtb16 promoter and the Egr2 consensus oligonucleotide probe, as shown above by electrophoretic mobility-shift assay (Fig. 4c) . In vivo, Egr2-deficient NKT cells failed to upregulate IL-2Rβ (CD122), in contrast to their wild-type counterparts, in chimeras reconstituted with a 1:1 mixture of wild-type and Egr2 ∆/∆ bone marrow (Fig. 7b) . To facilitate analysis of developmentally arrested Egr2-deficient NKT thymocytes, we crossed Egr2 ∆/∆ mice onto the V α 14-transgenic background and generated chimeric mice by introducing a 1:1 mixture of total bone marrow from the Egr2 ∆/∆ V α 14-transgenic (CD45.2 + ) mice and Egr2sufficient V α 14-transgenic (CD45.1 + ) mice (as donors) into irradiated wild type CD45.1 + hosts. Consistent with a defect in IL-2Rβ upregulation, Egr2-deficient NKT cells failed to upregulate the NK cell receptors NK1.1 and NKG2D to the amount observed in wild-type cells (Fig. 7c) . Quantitative RT-PCR analysis of Egr2-deficient and Egr2-sufficient NKT cells at stage 2, purified from these mixed chimeras, showed downregulation of Id2 (which encodes the transcriptional inhibitor Id2) in the absence of Egr2 (Fig. 7d,e) . That result was consistent with a function for Id2 in the survival of NKT cells and in acquisition of the NK cell program [23] [24] [25] . This analysis also showed that Egr2-deficient cells had twofold higher expression of Egr1 mRNA than Egr2-sufficient had (Fig. 7e) . We confirmed upregulation of Egr1 in Egr2-deficient cells by confocal microscopy of single cells (Fig. 7f) , which suggested that compensatory mechanisms promoted Egr1 expression at the transcriptional level in the absence of Egr2. Thus, Egr2 directly controlled the induction of IL-2Rβ at a late stage of NKT cell development.
DISCUSSION
Published reports have indicated that Egr2 is selectively required for the survival of developing NKT thymocytes. Here we have shown that higher and sustained Egr2 expression was induced downstream of TCR signaling in precursors of NKT cells and that Egr2 was directly connected to the key molecular checkpoints that define commitment to the NKT lineage and progression through the three developmental stages. These results suggested that Egr2 not only induced the early lineage-defining transcription factor PLZF but also controlled downstream expression of IL-2Rβ.
PLZF directs the acquisition of effector properties, such as upregulation of CD44, downregulation of CD62L and dual production of IL-4 and interferon-γ, that define the progression from stage 1 to stage 2, but other factors, including Egr1 and Egr2, are needed to promote survival and induce the rounds of cell division that characterize this transition. Likewise, IL-2Rβ is required for responsiveness to IL-15 and the subsequent terminal differentiation to stage 3, but its expression is only part of the program that controls the terminal differentiation of NKT thymocytes. More intricate connections that define the regulatory network that presides over commitment to the NKT cell fate and NKT cell differentiation are expected. For example, Egr2 is essential for upregulation of Id2, which is not only important for NKT cell survival in the periphery 24 but is also critical for NK cell differentiation 23, 25 . Studies of myeloid cells have shown binding of PLZF to the Id2 promoter 26 , and in preliminary studies of human NKT cells, ChIP-seq analysis identified the binding of Egr2 to a conserved Egr-binding site in the promoter of Id2 (data not shown), which highlights potential common targets of Egr2 and PLZF in the cooperative orchestration of NKT cell development.
Although Egr2 is clearly central to NKT cell development, our studies did not fully elucidate the precise role of Egr1 in wild-type NKT thymocytes. Egr1 expression was also higher at the earliest stages of NKT development and might contribute to the induction of PLZF in a way that is redundant with Egr2. Alternatively, Egr1 might be recruited to the Zbtb16 promoter in Egr2-deficient thymocytes only because of its compensatory increase in the absence of Egr2. There is precedent for such compensatory pathways between Egr proteins in T cells 27 , and additional studies have suggested crosstalk between the calcineurin pathway upstream of Egr2 and mitogen-activated protein kinase signaling upstream of Egr1 during thymocyte development 28 . Finally, Egr1 might activate other mechanisms that redundantly control PLZF induction. We observed redundancy between Egr1 and Egr2 for the induction of PLZF but not for IL-2Rβ, for which Egr2 alone was required; this allowed the identification of two Egr protein-controlled checkpoints in NKT cell development.
The tight developmental sequence that links the positive selection of NKT thymocytes with more induction of Egr2 and Egr1 and upregulation of PLZF suggests that TCR signaling by agonist self ligands is the trigger of this differentiation pathway. That hypothesis was supported by the experimental induction of Zbtb16 mRNA in an Egr-dependent manner after in vivo injection of agonist antibody to TCRβ. It is also consistent with a published report of PLZF induction in γδ T cells by anti-TCR in an in vitro OP9 stromal cell-based culture assay 29 . The extent to which other TCR signaling branches are overstimulated during NKT cell development is unclear at present and awaits single-cell studies of other signaling molecules. It is noteworthy in that context that expression of nur77, another early gene induced by TCR activation, is higher in NKT thymocytes than in conventional T cells in a green fluorescent protein reporter system 30 .
TCR signaling in developing NKT cells occurs in the context of homotypic interactions between thymocytes, with recruitment of members of the Slam family of proteins that signal through the adaptor SAP and the kinase Fyn 18 developmental arrest of NKT cells at stage 0, but some induction of Zbtb16 is nevertheless observed 4 , which suggests that SLAM-SAP signaling may not be required. However, a role for this signaling pathway in sustaining high expression of Egr2 should be explored. In addition to the early increase in Egr2, which was important for PLZF induction, Egr2 expression was critical for the activation of IL-2Rβ and transition to stage 3 at a later time point in development. Whether continued TCR signaling or additional regulatory pathways were responsible for sustained Egr2 expression is unclear. For example, the microRNA miR-150, which is selectively downregulated in NKT cells 32 , is reported to suppress Egr2 in gastric cancer cells 33 . In addition, other mechanisms that regulate Egr2 and involve the Egr1 and Egr2 corepressor Nab-2, and the zinc-finger transcription factor Gfi-1 have been reported in myeloid cells 14 .
Various studies have suggested that differences in TCR signaling, perhaps due to recognition of agonist ligands, underlie the unique developmental programs of T cell subsets such as NKT cells, γδ T cells, intestinal intraepithelial CD8αα TCRαβ cells and regulatory T cells [34] [35] [36] [37] . Few studies, however, have identified critical links between TCR signaling elements and lineage commitment. For example, whereas NFAT and the NF-κB transcription factor subunit c-Rel are important for the induction of Foxp3 in the regulatory T cell lineage [38] [39] [40] , overactivation of these pathways has not been demonstrated. Moreover, a specific role for Egr3 has been proposed in the development of epidermal γδ T cells, but its expression pattern and the gene-regulatory network used by Egr3 in this context remain unknown 41 . Our results not only have provided molecular evidence of TCR overstimulation in NKT cell precursors but have also identified a direct connection between an early signaling-dependent transcription factor and the induction of signature genes that control key checkpoints in NKT cell development. Similar mechanisms whereby the intensity and duration of signaling is 'translated' into distinct lymphoid cell fates 42, 43 probably operate in other models of lymphoid differentiation.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/. Accession codes. GEO: ChIP sequencing data, GSE34254.
Note: Supplementary information is available on the Nature Immunology website.
